Study objective: Intermittent positive pressure ventilation (IPPV) can be delivered via various oral, nasal, or oronasal interfaces as an alternative to tracheostomy for up to 24 h of ventilatory support. Nocturnal nasal IPPV is often associated with frequent transient but at times severe oxyhemoglobin desaturations (dSaO2s) and sleep fragmentation. The purpose of this study was to determine if nocturnal mouthpiece IPPV is also associated with dSaO2s and sleep disruption. Design: Twenty-seven postpolio ventilator-assisted individuals (VAIs) using mouthpiece IPPV with little or no ventilator-free breathing time (VFBT) underwent nocturnal oxyhemoglobin saturation (SaO2) monitoring. In addition, 15 underwent nocturnal capnography and 13 underwent polysomnography. Results: Mean nocturnal SaO2 was normal in 22 of 27 and maximum end-tidal Pco2 was normal in 12 of 15 VATs. Use of lipseal retention for nocturnal mouthpiece Intermittent positive pressure ventilation (IPPV) delivered via a nasal interface has been described as a method for assisting or supporting inspiratory muscle function and alveolar ventilation for individuals with acute or chronic ventilatory failure of various causes, including prelung transplantation cystic fibrosis,' chronic obstructive pulmonary disorders,2 severe kyphoscoliosis,3 and various neuromuscular diseases.4'5 Although mouthpiece IPPV has not had wide application thus far, it has been used for more severely affected individuals, for far longer periods of time, and is ideal for 24-h support.6 Both techniques can also alleviate symptoms of chronic alveolar hypoventilation (CAH), ameliorate or normalize daytime blood gas values, and improve mean nocturnal oxyhemoglobin saturation (SaO2) . [5] [6] [7] [8] Although improved, however, mean nocturnal SaO2 has not been found to be normal in nasal IPPV users.3,5,9 A recent study of 
RESULTS
The results of the noninvasive blood gas monitoring are listed in Table 1 . VAI 1 used mouthpiece IPPV with a lipseal (lipseal IPPV) for 10 years before awakening on several occasions with tachycardia. He was described as "snoring" through his nose before awakening. He subsequently sealed his nose every night by placing cotton pledgets into his nostrils and covering them with strips of tape (Micropore, 3M, Minneapolis). He continues to use this airtight system and has had no further episodes of tachycardia or snoring. His polysomnography showed 19 "central" apneas, 3.1 /h, with the longest duration of 25 s. These were not associated with dSaO2s. The "apneas" were classified as central in origin since there was no detected movement of the chest or abdomen. Since this VAI was on a regimen of fixed rate ventilatory support, the "apneas" must have been from transient tongue or glottic obstruction to air flow. This VAI was also studied using nocturnal nasal IPPV. He maintained a mean SaO2 of 97%, low of 91%, and a mean of three dSaO2s of greater than 3%/h. VAI 4 used low-flow oxygen in addition to ventilatory support because of persistent dSaO2 in the presence of normal end-tidal Pco2 both when awake and asleep. For VAI 6, the lipseal was padded at the four corners (with Otoform K R, Dreve, Unna, Germany) to decrease the air leakage observed during previous studies. VAI 8, with a thick mustache, had air escape from the upper border of the lipseal that repeatedly slipped down below the mustache. He was dyspneic and symptomatic for CAH. He used increasing periods of mouthpiece IPPV during daytime hours and was converted to nasal IPPV overnight on which his mean SaO2 was 97%, low 92%, worst hour mean 96% with 0.3 dSaO2s per hour and a maximum end-tidal Pco2 of 46 cm H20. VAI 7 had no VFBT when supine but was able to breathe autonomously with hypercapnia when erect. Sleeping while sitting and using supplemental oxygen failed to improve SaO2 and hypercapnia worsened. The addition of low-flow oxygen to lipseal IPPV improved nocturnal Sa02 from a mean of 82% REMIj   1  75  5  14  6  0  2  7  12  40  22  19  3  18  30  8  17  26  4  31  17  0  40  5  5  1 1  26  26  12  25  6  28  3  19  20  28  7  20  35  1  27  1 1  8  18  11  28  16  19  9  14  49  14  0  17  10  5 IREM sleep as a percentage of SPT, normal=17-31%. '5 to 92% but there were a mean of 40 dSaO2s per hour and a maximum end-tidal Pco2 of 48 mm Hg. He used mouthpiece IPPV with low-flow oxygen for 4 years but in 1992 switched to a closed, custom lipseal system using a strapless interface with bite-plate retention and an outer shell covering the nose and mouth. Supplemental oxygen therapy was discontinued and nocturnal SaO2 values improved to a mean of 94% with five dSaO2s per hour. He also reported less fatigue and felt better rested in the morning.
VAI 27 was converted from 24-h rocking bed ventilator use to mouthpiece IPPV in 1980. In 1988, using nocturnal mouthpiece IPPV without a lipseal, his SaO2 mean was 89%, the low was 72%, the worst hour mean was 86%, and it was below 90% for 59% of the night. He was converted to lipseal IPPV and the subsequent sleep oximetry results over a twonight period are averaged in Table 1 . The percentage of time the 13 VAIs who underwent polysomnography spent in the stages of sleep and their sleep efficiencies are indicated in Tables 2  and 3 . The percentage of time that 5 of the 13 mouthpiece IPPV users leaked air out of their nostrils during the ventilator inspiratory and expiratory cycles is noted in Table 4 . The three VAIs who used mouthpiece IPPV without a lipseal or with a lipseal held by only one elastic strap (Table 1) , at the nadirs of their dSaO2s and without any apparent cognizance of having been aroused, were consistently observed to grip their mouthpieces with the teeth and oral musculature to eliminate air leakage and thereby increase alveolar ventilation and normalize SaO2.
DISCUSSION
The SaO2 monitoring is accurate at any point in time to within 2% of actual SaO2 for values of 70% or greater." End-tidal Pco2 is an accurate gauge of alveolar ventilation for VAIs without severe pulmonary diffusion deficits or cardiovascular failure.12 It, thus, should have been accurate in our population provided that an adequate sampling of end-alveolar expiratory flow could be analyzed. The fact that expiratory passage of air through the nose occurred less than 65% of the time and during an average of only 33 ± 27% of the total sleep time for the five VAIs for whom it was measured implies that the maximum end-tidal Pco2 measurements could only have been higher than what was actually observed.
Despite the fact that only 3 of the 27 mouthpiece IPPV users studied had sufficient vital capacity (VC) to support VFBT for over 10 min when supine and only 1 used supplemental oxygen, all slept supine, 22 (82%) of the nocturnal oximetry studies yielded normal mean SaO2, and 12 of 15 had maximum end-tidal Pco2 levels under 45 mm Hg. The lowest mean nocturnal SaO2 for anyone using nocturnal mouthpiece IPPV with the mouthpiece properly retained by a two-strap lipseal was 92%. The VAIs using mouthpieces or bite-plates without firm lipseal retention had a "sawtooth" pattern of dSaO2 and mean SaO2 under 95%. This pattern is similar to that which has been reported during nocturnal nasal IPPV use.3 '5 These VAIs and all whom we have subsequently observed asleep using mouthpiece IPPV without an adequate lipseal have demonstrated loosening of grip of the mouthpiece, without it falling from the mouth, accompanied by air leakage and dSaO2. At the nadir of the dSaO2, this has invariably been followed by the VAI firmly regripping the mouthpiece with his teeth and oral musculature to eliminate leakage until SaO2 had increased to the preleakage baseline.
Both nasal and mouthpiece IPPV, without adequate oral-nasal seal to prevent insufflation leakage, are open systems. When a dSaO2 caused by excessive insufflation air leakage occurs to a certain degree, the VAI usually undergoes a brief arousal, of which he is unaware, or lightening of sleep stage, and muscular activity occurs to seal off the nasal or oral leakage. This improves alveolar ventilation and returns SaO2 to baseline.9 These transient 4% or greater dSaO2s tend to become more severe in VAIs who are hypercapnic during daytime as well as overnight. Of the 13 mouthpiece IPPV users who underwent polysomnography, only five had mean SaO2 less than 95% for 1 h or more, SaO2 less than 90% for 6% or more of the recording time, and many transient dSaO2s. Three of these five used mouthpiece IPPV without a lipseal (cases 7 and 12) or withi a lipseal with inadequate retention (case 8). All three were also symptomatic with hypoventilation during daytime hours but did not use daytime ventilatory assistance. For VAIs 8 and 12, this was in large part because they were functional ambulators. VAI 7 subsequently supplemented nocturnal nasal IPPV with daytime mouthpiece IPPV and now uses IPPV 24 h/d. The normalization of central nervous system chemotaxic sensitivity in this VAI appears to have resulted in earlier central nervous system-mediated recruitment of oropharyngeal muscular activity to diminish insufflation leakage during sleep and restore normal alveolar ventilation and SaO2 around-the-clock. VAI 8 now also uses daytime mouthpiece IPPV periodically and VAI 12 has switched to using nocturnal strapless oral-nasal interface IPPV.13"14
The five VAIs for whom leakage time was quantitated had inspiratory cycle (insufflation) leakage during a mean of 43 ± 21% of total sleep time. Since ventilator settings, especially those of VAIs using volume-triggered ventilators, exceeded that which would have been necessary to achieve adequate alveolar ventilation in a closed system, it was not surprising that insufflation leakage occurred from 3% to 100% of the time the VAIs were awake to avoid hyperventilation. It is also understandable that the VAIs using the higher ventilator pressures and volumes tended to have the longest leakage periods. The pressure-triggered ventilators compensate for some insufflation leakage and higher delivered volumes permit the VAI the convenience of taking fewer "leakless" mouthpiece-assisted breaths per minute.
Insufflation leakage is stopped or markedly decreased and SaO2 normalized during the oropharyngeal muscular activity triggered by dSaO2s. This can occur during sleep whether the VAI is using mouthpiece IPPV with or without a lipseal. Firm lipseal retention with completely passive seal of the lips and mouth can change the sawtooth dSaO2 pattern into a normal pattern that reflects effective compensation of nasal air leakage. Because no central nervous system triggered muscular activity is necessary to maintain adequate alveolar ventilation in this case, more restful sleep with less sleep fragmentation would be expected this way than during mouthpiece IPPV without a lipseal or during nasal IPPV. No method has been reported to be successful for compensating or preventing excessive oral air leakage during nasal IPPV except for taping the mouth closed, a procedure tolerated by few, or using a plugged lipseal.15 Therefore, the use of lipseal IPPV is a logical alternative to nasal IPPV when oral leakage leads to significant dSaO2s. We have routinely switched nasal IPPV users with acute respiratory failure due to nasal congestion precluding effective use of nasal IPPV to nocturnal lipseal IPPV.
Total arousals, sleep stage changes, and arousals with change of SaO2 were not calculated in this study. However, percentages of sleep in the various stages were relatively normal. Further, the relative absence of the frequent transient dSaO2s associated with sleep disturbances in studies of nocturnal nasal IPPV users with severe kyphoscoliosis9 implies that sleep may be more restful for lipseal IPPV users. This deserves further study. The one VAI with no measurable VC who was studied using both lipseal and nasal IPPV had more dSaO2s using the latter.
Using an essentially closed system with a lipseal and nostril plugging or switching to masks that cover both nose and mouth has been shown to normalize nocturnal SaO2 by eliminating insufflation leakage and, thereby, any need to resort to centrally mediated mechanisms for effective alveolar ventilation. 13 In conclusion, the nocturnal use of mouthpiece IPPV should be with firm lipseal retention, otherwise insufflation leakage during sleep can cause subnormal SaO2 and probably sleep fragmentation similar to that seen in nocturnal nasal IPPV users. During periods of excessive insufflation leakage, central nervous system mediated muscular activity occurs at the SaO2 nadirs to eliminate leakage and renormalize SaO2. For those who continue to have periods of dSaO2 despite firm lipseal retention, the use of nasal pledgets or a strapless oral-nasal interface for IPPV can normalize alveolar ventilation and sleep SaO2 without resorting to endotracheal intubation.13 Thus, this study supports the safety of noninvasive IPPV systems as alternatives to tracheostomy IPPV for up to 24 h of ventilatory support for selected populations.
